Valerie K. Israel
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Cancer Treatment and Pharmacology, Cancer therapeutics and mechanisms, Lung Cancer Diagnosis and Treatment
Most-Cited Works
- → Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial(2001)1,127 cited
- → Twice-Weekly Paclitaxel and Weekly Carboplatin With Concurrent Thoracic Radiation Followed by Carboplatin/Paclitaxel Consolidation for Stage III Non–Small-Cell Lung Cancer: A California Cancer Consortium Phase II Trial(2001)97 cited
- → Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V leiden(1997)58 cited
- → Chemotherapy-Induced Activation of Hemostasis: Effect of a Low Molecular Weight Heparin (Dalteparin Sodium) on Plasma Markers of Hemostatic Activation(2002)51 cited
- MDR1 gene expression in primary and advanced breast cancer.(1999)
- → Paclitaxel 3-hour infusion given alone and combined with carboplatin: Preliminary results of dose-escalation trials(1996)31 cited
- → Intraperitoneal 5-fluoro-2?-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity study(1995)27 cited
- → Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium Trial(2001)22 cited
- → Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinoma(2002)20 cited
- → Phase I Trial of the Combination of Irinotecan, Paclitaxel, and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer(2001)20 cited